Table 1.
Design Characteristics of PNRP Projects
| Boston | Chi-Access | Chi-VA | Denver | Ohio | Rochester | San Ant | Tampa | Wash-DC | |
|---|---|---|---|---|---|---|---|---|---|
| Targeted Cancer Sites | |||||||||
| Breast | X | X | X | X | X | X | X | X | |
| Cervical | X | X | X | X | |||||
| Colorectal | X | X | X | X | X | ||||
| Prostate | X | X | |||||||
| Design | |||||||||
| Randomized – Individual level | X | X | |||||||
| Randomized – Group level | X | X | |||||||
| Non-Randomized | X | X | X | X | X | ||||
| Unit of Assignment | |||||||||
| Individual | X | X | |||||||
| Group | X | X | X | X | X | X | X | ||
| Controls | |||||||||
| Actively Recruited Controls | X | X | X | ||||||
| Medical Records-Based Controls | X | X | X | X | X | X | |||
| Clinics/Care sites Number (#Nav/#Ctl) | 6 (3/3) | 9 (5/4) | 1 | 1 | 16 (8/8) | 11 | 5 (2/3) | 12 (7/5) | 15 (8/7) |
| Intervention Scope | |||||||||
| Abnormality to Diagnosis | X | X | X | X | X | X | X | X | X |
| Diagnosis to Start of Treatment | X | X | X | X | X | X | X | X | |
| Start to Completion of Treatment | X | X | X | X | X | X | X | X | |
| Enrollment as of 6/1/11 | |||||||||
| Total subjects | 3042 | 1023 | 513 | 1249 | 674 | 344 | 1052 | 1320 | 2594 |
| Subjects with cancer | 196 | 118 | 0 | 171 | 27 | 321 | 9 | 53 | 349 |
| Total PNRP Enrollment (all projects) | |||||||||
| Total subjects 11,643 | |||||||||
| Total subjects with cancer 1,048 | |||||||||